Comprehensive management of pregnant woman with Sjögren's syndrome
Downloads
HIGHLIGHTS
1. Sjögren's syndrome is a chronic autoimmune disease that attacks the exocrine glands, especially lacrimal and salivary glands.
2. Comprehensive management of pregnant women with Sjögren's syndrome was described.
3. Clinical and laboratory examination, risk assessment and also preconception counseling before planning pregnancy are needed by women with Sjögren's syndrome.
ABSTRACT
Objective: To illustrate the comprehensive management of pregnant women with Sjögren syndrome.
Case Report: A 24 years old women came to Dr. Soetomo General Academic Hospital, Surabaya, Indonesia, due to Sjögren syndrome in 35/36 weeks of gestasional age for routine examination. She was first diagnosed with Sjögren syndrome in February 2018 because she complained of dry eyes and hair fall out. This was her first pregnancy. Laboratory result showed positive ANA test. The patient had hypertension with controlled blood preasure and dry eyes. The patient was diagnosed with primigravida 35-36 weeks of pregnancy, single live intrauterine, head presentation, IUGR, screening preeclampsia was positive, and there was complication with Sjögren's syndrome. The patient was treated by multidisciplinary team consisting of obstetricians, internists, ophthalmologists and neonatologists.
Conclusion: Sjögren's syndrome is a chronic autoimmune disease that attacks the exocrine glands, especially lacrimal and salivary glands. The exact cause of Sjögren's syndrome is still not known. Women with Sjögren's syndrome should have clinical and laboratory examination, risk assessment and also preconception counseling before planning pregnancy because Sjögren syndrome was a rare case during pregnancy. Close monitoring and proper management was imperative to detect the early complication.
Patel R, Shahane A. The epidemiology of Sjögren's syndrome. Clin Epidemiol. 2014;6:247-55. doi: 10.2147/CLEP.S47399. PMID: 25114590; PMCID: PMC4122257.
Gupta S, Gupta N. Sjögren Syndrome and pregnancy: A literature review. Perm J. 2017;21:16-047. doi: 10.7812/TPP/16-047. Epub 2016 Nov 9. PMID: 28080954; PMCID: PMC5267941.
Hussein SZ, Jacobsson LT, Lindquist PG, et al. Pregnancy and fetal outcome in women with primary Sjogren's syndrome compared with women in the general population: a nested case-control study. Rheumatology (Oxford). 2011;50(9):1612-7. doi: 10.1093/rheumatology/ker077. Epub 2011 Apr 29. PMID: 21531959.
Meena A, Hema T. Successful management of a case of pregnancy with Sjögren Syndrome. International Journal of Scientific Research 2020;9:11-2. doi: 10.36106/ijsr.
Pasoto SG, Adriano de Oliveira Martins V, Bonfa E. Sjögren's syndrome and systemic lupus erythematosus: links and risks. Open Access Rheumatol. 2019;11:33-45. doi: 10.2147/OARRR. S167783. PMID: 30774485; PMCID: PMC635 7904.
Tong L, Koh V, Thong BY. Review of autoantigens in Sjögren's syndrome: an update. J Inflamm Res. 2017;10:97-105. doi: 10.2147/JIR.S137024. PMID: 28848359; PMCID: PMC5557906.
Khalele BAEO. Sjögren's syndrome in a 25-year-old female: A case study. Future Dental Journal of Egypt. 2016;2:94-8. doi: 10.1016/j.fdj.2016.10.001.
Brandt JE, Priori R, Valesini G, et al. Sex differences in Sjögren's syndrome: a comprehensive review of immune mechanisms. Biol Sex Differ. 2015;6:19. doi: 10.1186/s13293-015-0037-7. PMID: 26535108; PMCID: PMC4630965.
Elliott B, Spence AR, Czuzoj-Shulman N, et al. Effect of Sjögren's syndrome on maternal and neonatal outcomes of pregnancy. J Perinat Med. 2019;47(6):637-42. doi: 10.1515/jpm-2019-0034. PMID: 31287800.
Mavragani CP, Moutsopoulos HM. Sjögren's syndrome: Old and new therapeutic targets. J Autoimmun. 2020;110:102364. doi: 10.1016/j.jaut. 2019.102364. Epub 2019 Dec 9. PMID: 31831255.
Nasef N, Hafez M, Bakr A. Neonatal lupus erythematosus. Journal of Neonatology & Clinical Pediatrics. 2014;1:002. doi: 10.24966/NCP-878X/ 100002
Ambrosi A, Wahren-Herlenius M. Congenital heart block: evidence for a pathogenic role of maternal autoantibodies. Arthritis Res Ther. 2012;14(2):208. doi: 10.1186/ar3787. PMID: 22546326; PMCID: PMC3446439.
Tarn JR, Tripp NH, Lendrem DW, et al. Symptom-based stratification of patients with primary Sjögren's syndrome: Multi-Dimensional character-isation of international observational cohorts and reanalyses of randomised clinical trials. The Lancet Rheumatology. 2019;1(2):85-94. doi: 10.1016/ S2665-9913(19)30042-6.
Sandhya, P. Management of Sjögren's syndrome During Pregnancy. In: Sharma, S. (eds) Women's Health in Autoimmune Diseases, 2020:187-96. Springer, Singapore. doi: 10.1007/978-981-15-0114-2_18.
Tam WK, Hsu HC, Hsieh MH, et al. Association of Anti-Ro/Sjögren's syndrome type A Antibodies and Complete Atrioventricular Block in an Adult With Sjögren's syndrome. Arch Rheumatol. 2017;33(2) :225-9. doi: 10.5606/ArchRheumatol.2018.6492. PMID: 30207577; PMCID: PMC 6117129.
Batra AS, Balaji S. Fetal arrhythmias: Diagnosis and management. Indian Pacing Electrophysiol J. 2019;19(3):104-9 doi: 10.1016/j.ipej.2019.02.007. Epub 2019 Feb 25. PMID: 30817991; PMCID: PMC6531664.
Lester S, Rischmueller M, Tan L, et al. Sicca symptoms and their association with chronic rhinosinusitis in a community sample. Open Rheumatol J. 2012;6:170-4. doi: 10.2174/187431 2901206010170. Epub 2012 Jun 28. PMID: 2280 2916; PMCID: PMC3396280.
Putra RS, Najirman. Treatment of Systemic Lupus Erythematosus with Anti-SSA and SSB positive pregnancies. Bioscientia Medicina: Journal of Biomedicine and Translational Research. 2022;6(3) :1523-29. doi: 10.37275/bsm.v6i3.470.
Akpek EK, Bunya VY, Saldanha IJ. Sjögren's syndrome: More than just dry eye. Cornea. 2019 May;38(5):658-61. doi: 10.1097/ICO.0000000000 001865. PMID: 30681523; PMCID: PMC6482458.
Gayed M, Gordon C. Pregnancy and rheumatic diseases. Rheumatology (Oxford). 2007;46(11) :1634-40. doi: 10.1093/rheumatology/kem156. Epub 2007 Jul 10. PMID: 17623748.
Copyright (c) 2022 Majalah Obstetri & Ginekologi
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
1. Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
3. The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.